Alibaba Health Valuation
| ALBBY Stock | USD 9.61 0.64 6.24% |
At this time, the firm appears to be overvalued. Alibaba Health Infor shows a prevailing Real Value of $8.79 per share. The current price of the firm is $9.61. Our model approximates the value of Alibaba Health Infor from analyzing the firm fundamentals such as Return On Equity of 0.0088, profit margin of 0.01 %, and Current Valuation of 14.83 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Alibaba Health's price fluctuation is moderately volatile at this time. Calculation of the real value of Alibaba Health Infor is based on 3 months time horizon. Increasing Alibaba Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Alibaba Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alibaba Pink Sheet. However, Alibaba Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.61 | Real 8.79 | Hype 9.61 | Naive 10.24 |
The intrinsic value of Alibaba Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alibaba Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Alibaba Health Information helps investors to forecast how Alibaba pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alibaba Health more accurately as focusing exclusively on Alibaba Health's fundamentals will not take into account other important factors: Alibaba Health Total Value Analysis
Alibaba Health Information is presently forecasted to have takeover price of 14.83 B with market capitalization of 11.01 B, debt of 135.41 M, and cash on hands of 10.55 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Alibaba Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
14.83 B | 11.01 B | 135.41 M | 10.55 B |
Alibaba Health Investor Information
The company has Price/Earnings (P/E) ratio of 210.12. Alibaba Health Infor had not issued any dividends in recent years. Alibaba Health Information is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Alibaba Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Alibaba Health has an asset utilization ratio of 107.16 percent. This suggests that the Company is making $1.07 for each dollar of assets. An increasing asset utilization means that Alibaba Health Information is more efficient with each dollar of assets it utilizes for everyday operations.Alibaba Health Profitability Analysis
The company reported the revenue of 20.58 B. Net Loss for the year was (265.56 M) with profit before overhead, payroll, taxes, and interest of 4.11 B.About Alibaba Health Valuation
Our relative valuation model uses a comparative analysis of Alibaba Health. We calculate exposure to Alibaba Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Alibaba Health's related companies.Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong. Alibaba Health operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 1849 people.
8 Steps to conduct Alibaba Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Alibaba Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Alibaba Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Alibaba Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Alibaba Health's revenue streams: Identify Alibaba Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Alibaba Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Alibaba Health's growth potential: Evaluate Alibaba Health's management, business model, and growth potential.
- Determine Alibaba Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Alibaba Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Alibaba Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 13.5 B | |
| Forward Price Earnings | 188.6792 | |
| Retained Earnings | -1.3 B |
Additional Tools for Alibaba Pink Sheet Analysis
When running Alibaba Health's price analysis, check to measure Alibaba Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alibaba Health is operating at the current time. Most of Alibaba Health's value examination focuses on studying past and present price action to predict the probability of Alibaba Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alibaba Health's price. Additionally, you may evaluate how the addition of Alibaba Health to your portfolios can decrease your overall portfolio volatility.